ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 143095 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 143095; 2) Community: the network communities that were significantly associated with the response to NSC 143095; 3) Molecule: the relationships between components within communities and NSC 143095; 4) MDR: the compounds that were significantly associated with the NSC 143095.

NSC Compound Enrichment Correlation
NSC 615441 1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride 0.000706163530262832 0.65233064
NSC 625507 Null 0.000706163530262832 0.3144173
NSC 666596 Null 0.000706163530262832 0.4396193
NSC 670995 Null 0.000706163530262832 0.65556781
NSC 699491 Epidoxoform 0.000706163530262832 0.43246956
NSC 700125 Null 0.000706163530262832 0.47613272
NSC 746087 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.000706163530262832 0.40301933
NSC 112758 Rubomycin 0.000751340623722758 0.33803891
NSC 134725 K-33 0.000751340623722758 0.52451589
NSC 301477 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- 0.000751340623722758 0.4972737
Total:97  Current:3    [First] [Prev] [Next] [Last]